Phenomenon of rifampicin-induced discolouration of body fluids.
Morgan
J R
JR
Clarke
K W
KW
Brear
S G
SG
D000368:Aged; D000904:Antibiotics, Antitubercular / Q000627:therapeutic use / Q000652:urine*; D000995:Antitubercular Agents / Q000627:therapeutic use; D002863:Chromogenic Compounds / Q000378:metabolism*; D004347:Drug Interactions; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D011718:Pyrazinamide / Q000627:therapeutic use; D012293:Rifampin / Q000031:analogs & derivatives / Q000627:therapeutic use / Q000652:urine*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000904:Antibiotics, Antitubercular; D000995:Antitubercular Agents; D002863:Chromogenic Compounds; D011718:Pyrazinamide; C032393:25-deacetylrifampicin; D007538:Isoniazid; D012293:Rifampin